CA Stock MarketDetailed Quotes

TTI Thiogenesis Therapeutics Corp

Watchlist
  • 0.600
  • 0.0000.00%
15min DelayTrading Oct 30 16:00 ET
27.30MMarket Cap-5454P/E (TTM)

Thiogenesis Therapeutics Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
7.06%4.97M
3.86%5.52M
14.21%7.08M
14.21%7.08M
125.03%3.63M
--4.64M
51.86%5.32M
9,805.77%6.2M
9,805.77%6.2M
2,071.09%1.61M
-Cash and cash equivalents
7.06%4.97M
3.86%5.52M
14.21%7.08M
14.21%7.08M
125.03%3.63M
--4.64M
51.86%5.32M
9,805.77%6.2M
9,805.77%6.2M
2,071.09%1.61M
Receivables
0.88%47.56K
404.29%95.62K
52.38%85.32K
52.38%85.32K
110.04%45.29K
118.22%47.15K
525.19%18.96K
-66.76%55.99K
-66.76%55.99K
2,835.05%21.56K
-Accounts receivable
-89.52%1.32K
-63.13%6.99K
-17.97%6K
-17.97%6K
-90.77%1.99K
-41.55%12.63K
525.19%18.96K
-44.62%7.32K
-44.62%7.32K
2,835.05%21.56K
-Taxes receivable
33.95%46.24K
--88.63K
469.48%79.31K
469.48%79.31K
--43.3K
--34.52K
----
--13.93K
--13.93K
----
-Other receivables
----
----
----
----
----
----
----
-77.62%34.74K
-77.62%34.74K
----
Prepaid assets
414.61%46.5K
642.59%68.59K
110.69%81.38K
110.69%81.38K
--9.23K
--9.04K
--9.24K
--38.62K
--38.62K
----
Total current assets
7.78%5.06M
6.38%5.69M
15.14%7.24M
15.14%7.24M
125.40%3.69M
110.06%4.7M
52.53%5.35M
2,623.46%6.29M
2,623.46%6.29M
1,475.40%1.64M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
7.78%5.06M
6.38%5.69M
15.14%7.24M
15.14%7.24M
125.40%3.69M
110.06%4.7M
52.53%5.35M
2,623.46%6.29M
2,623.46%6.29M
1,475.40%1.64M
Liabilities
Current liabilities
Current liabilities
-11.83%308.45K
33.57%344.6K
457.66%1.71M
457.66%1.71M
295.94%320.44K
404.69%349.83K
-74.97%258K
-76.25%307.15K
-76.25%307.15K
-90.23%80.93K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-11.83%308.45K
33.57%344.6K
457.66%1.71M
457.66%1.71M
295.94%320.44K
404.69%349.83K
-74.97%258K
-76.25%307.15K
-76.25%307.15K
-90.23%80.93K
Shareholders'equity
Share capital
40.69%15.66M
40.69%15.66M
34.89%15.01M
34.89%15.01M
70.84%11.13M
70.97%11.13M
75.12%11.13M
957.18%11.13M
957.18%11.13M
425,462.77%6.51M
-common stock
40.69%15.66M
40.69%15.66M
34.89%15.01M
34.89%15.01M
70.84%11.13M
70.97%11.13M
75.12%11.13M
957.18%11.13M
957.18%11.13M
425,462.77%6.51M
Retained earnings
-54.04%-12.5M
-63.56%-11.85M
-80.30%-11.14M
-80.30%-11.14M
-63.88%-9.17M
-65.96%-8.11M
-64.93%-7.24M
-188.19%-6.18M
-188.19%-6.18M
-177.62%-5.6M
Gains losses not affecting retained earnings
19.76%1.6M
27.44%1.54M
60.52%1.66M
60.52%1.66M
121.25%1.41M
143.62%1.34M
135.16%1.2M
3,505.03%1.03M
3,505.03%1.03M
-50.71%635.75K
Total stockholders'equity
9.36%4.76M
5.00%5.34M
-7.58%5.53M
-7.58%5.53M
116.52%3.37M
100.64%4.35M
105.64%5.09M
663.29%5.98M
663.29%5.98M
314.66%1.55M
Total equity
9.36%4.76M
5.00%5.34M
-7.58%5.53M
-7.58%5.53M
116.52%3.37M
100.64%4.35M
105.64%5.09M
663.29%5.98M
663.29%5.98M
314.66%1.55M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 7.06%4.97M3.86%5.52M14.21%7.08M14.21%7.08M125.03%3.63M--4.64M51.86%5.32M9,805.77%6.2M9,805.77%6.2M2,071.09%1.61M
-Cash and cash equivalents 7.06%4.97M3.86%5.52M14.21%7.08M14.21%7.08M125.03%3.63M--4.64M51.86%5.32M9,805.77%6.2M9,805.77%6.2M2,071.09%1.61M
Receivables 0.88%47.56K404.29%95.62K52.38%85.32K52.38%85.32K110.04%45.29K118.22%47.15K525.19%18.96K-66.76%55.99K-66.76%55.99K2,835.05%21.56K
-Accounts receivable -89.52%1.32K-63.13%6.99K-17.97%6K-17.97%6K-90.77%1.99K-41.55%12.63K525.19%18.96K-44.62%7.32K-44.62%7.32K2,835.05%21.56K
-Taxes receivable 33.95%46.24K--88.63K469.48%79.31K469.48%79.31K--43.3K--34.52K------13.93K--13.93K----
-Other receivables -----------------------------77.62%34.74K-77.62%34.74K----
Prepaid assets 414.61%46.5K642.59%68.59K110.69%81.38K110.69%81.38K--9.23K--9.04K--9.24K--38.62K--38.62K----
Total current assets 7.78%5.06M6.38%5.69M15.14%7.24M15.14%7.24M125.40%3.69M110.06%4.7M52.53%5.35M2,623.46%6.29M2,623.46%6.29M1,475.40%1.64M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets 7.78%5.06M6.38%5.69M15.14%7.24M15.14%7.24M125.40%3.69M110.06%4.7M52.53%5.35M2,623.46%6.29M2,623.46%6.29M1,475.40%1.64M
Liabilities
Current liabilities
Current liabilities -11.83%308.45K33.57%344.6K457.66%1.71M457.66%1.71M295.94%320.44K404.69%349.83K-74.97%258K-76.25%307.15K-76.25%307.15K-90.23%80.93K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -11.83%308.45K33.57%344.6K457.66%1.71M457.66%1.71M295.94%320.44K404.69%349.83K-74.97%258K-76.25%307.15K-76.25%307.15K-90.23%80.93K
Shareholders'equity
Share capital 40.69%15.66M40.69%15.66M34.89%15.01M34.89%15.01M70.84%11.13M70.97%11.13M75.12%11.13M957.18%11.13M957.18%11.13M425,462.77%6.51M
-common stock 40.69%15.66M40.69%15.66M34.89%15.01M34.89%15.01M70.84%11.13M70.97%11.13M75.12%11.13M957.18%11.13M957.18%11.13M425,462.77%6.51M
Retained earnings -54.04%-12.5M-63.56%-11.85M-80.30%-11.14M-80.30%-11.14M-63.88%-9.17M-65.96%-8.11M-64.93%-7.24M-188.19%-6.18M-188.19%-6.18M-177.62%-5.6M
Gains losses not affecting retained earnings 19.76%1.6M27.44%1.54M60.52%1.66M60.52%1.66M121.25%1.41M143.62%1.34M135.16%1.2M3,505.03%1.03M3,505.03%1.03M-50.71%635.75K
Total stockholders'equity 9.36%4.76M5.00%5.34M-7.58%5.53M-7.58%5.53M116.52%3.37M100.64%4.35M105.64%5.09M663.29%5.98M663.29%5.98M314.66%1.55M
Total equity 9.36%4.76M5.00%5.34M-7.58%5.53M-7.58%5.53M116.52%3.37M100.64%4.35M105.64%5.09M663.29%5.98M663.29%5.98M314.66%1.55M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data